{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_period = \"third_quarter\", filing_year = 2016 and issue_code = \"MED\" sorted by filing_year descending", "rows": [[1872353, "20c97049-8944-485f-8827-56ab700561da", "Q3", "LOBBYIT.COM", 400487397, "BLADDER CANCER ADVOCACY NETWORK", 2016, "third_quarter", "MED", "Increase awareness of bladder cancer. Advocate in support of H. Res 282 and S. Res. 187, designating May as Bladder Cancer Awareness Month.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2016-09-29T19:27:46.897000-04:00"], [1872468, "e8ae0c7a-aced-4958-b14a-329e2603a457", "Q3", "NATURAL RESOURCE RESULTS LLC", 321555, "SHINE MEDICAL TECHNOLOGIES", 2016, "third_quarter", "MED", "Support NNSA grant to client for Molybdenum99 facility; support appropriations language for NNSA grant program to lift cap on grant program.", "Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2016-10-01T12:37:42.753000-04:00"], [1872550, "5af6f769-00f6-4f53-a818-4d4b59059525", "Q3", "MARSHALL BRACHMAN", 6848, "BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM", 2016, "third_quarter", "MED", "support funding for medical research programs", "HOUSE OF REPRESENTATIVES,SENATE", 33000, null, 0, 0, "2016-10-02T10:35:51.677000-04:00"], [1872636, "c4fe7b2f-e3ea-4ead-bcba-34d548dfa64c", "Q3", "RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)", 400361684, "VIJUK EQUIPMENT, INC.", 2016, "third_quarter", "MED", "Pharmaceutical labeling", "Food & Drug Administration (FDA)", 18750, null, 0, 0, "2016-10-03T09:50:00.690000-04:00"], [1873266, "c90358e7-fa59-4619-9d59-83796574070c", "Q3", "WAKE FOREST UNIVERSITY HEALTH SCIENCES", 6781, "WAKE FOREST UNIVERSITY HEALTH SCIENCES", 2016, "third_quarter", "MED", "VA Research Funding; Moonshot Cure Summit 6/29/16, follow -up; Regenerative Medicine Research Funding", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE", null, 130000, 0, 0, "2016-10-05T16:04:57.067000-04:00"], [1873353, "59c67d5f-2758-4630-859e-d3cbbb2897fa", "Q3", "AMERICAN COLLEGE OF CLINICAL PHARMACY", 57258, "AMERICAN COLLEGE OF CLINICAL PHARMACY", 2016, "third_quarter", "MED", "Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and  Medicare Part D plans.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE", null, 128875, 0, 0, "2016-10-06T10:09:33.290000-04:00"], [1873575, "a39bf29a-3a3e-492a-b7a1-3413a5f1edee", "Q3", "AMERICAN GASTROENTEROLOGICAL ASSOCIATION", 59650, "AMERICAN GASTROENTEROLOGICAL ASSOCIATION", 2016, "third_quarter", "MED", "Lobbied in support of funding for digestive disease research at NIH, VA and DoD.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, 80000, 0, 0, "2016-10-06T16:12:30.093000-04:00"], [1873601, "98ad3ed9-a90f-42d7-b675-ef726476488a", "Q3", "AMERICAN COLLEGE OF EMERGENCY PHYSICIANS", 1967, "AMERICAN COLLEGE OF EMERGENCY PHYSICIANS", 2016, "third_quarter", "MED", "H.R.6-21st Century Cures Act\nH.R.2646-Helping Families in Mental Health Crisis Act of 2015\nH.R.3299-Strengthening Public Health Emergency Response Act\nH.R.5243-Zika Response Appropriations Act\n\nS.1893-Mental Health Awareness and Improvement Act of 2015\nS.1945-Mental Health Reform Act of 2015", "HOUSE OF REPRESENTATIVES,SENATE", null, 512329, 0, 0, "2016-10-06T22:34:59.390000-04:00"], [1873930, "bb7dac39-bc4b-4df2-9b44-8663d09e67f2", "Q3", "HOLLAND & KNIGHT LLP", 18466, "AMERICAN MEDICAL TECHNOLOGISTS", 2016, "third_quarter", "MED", "Payment and reimbursement for Medicare clinical laboratory testing; Medicare Part B reimbursement policies; Adjustments to Medicare Clinical Laboratory Fee Schedule; Affordable Care Act implementation; Regulation of laboratory-developed tests as medical devices by the Food and Drug Administration; Funding to support harmonization of clinical laboratory test results.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2016-10-07T16:21:47.833000-04:00"], [1874029, "751d77a8-7248-4861-94b7-c512bbaa277e", "Q3", "PARRY, ROMANI, DECONCINI & SYMMS", 30792, "AIDS HEALTHCARE FOUNDATION", 2016, "third_quarter", "MED", "Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2016 - Support funding for medical treatments for HIV positive patients.  Support appropriate funding for the ADAP program.", "HOUSE OF REPRESENTATIVES,SENATE", 36000, null, 0, 0, "2016-10-08T11:39:56-04:00"], [1874094, "7369591d-c436-4b08-aa90-92c127ff3052", "Q3", "O'NEILL AND ASSOCIATES", 73134, "POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN)", 2016, "third_quarter", "MED", "Medicare advantage and healthcare reform", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2016-10-09T15:07:19.353000-04:00"], [1874222, "4897468a-0ccf-4981-a2f0-20fca6491b0b", "Q3", "FEDERAL SOLUTIONS, LLC", 311371, "MISSISSIPPI STATE UNIVERSITY", 2016, "third_quarter", "MED", "Labor/HHS/Education Appropriation Bill: Provisions relating to disease research.", "Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE", 50000, null, 0, 0, "2016-10-10T12:09:42.717000-04:00"], [1874240, "bd7b7f52-c34b-48e5-bdb7-945a5dea0732", "Q3", "FEDERAL SOLUTIONS, LLC", 311371, "JACKSONVILLE STATE UNIVERSITY", 2016, "third_quarter", "MED", "Labor/HHS/Education Appropriations Bill: Provisions relating to disease research, education and development.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2016-10-10T12:13:45.737000-04:00"], [1874301, "88a04952-ba19-4065-9259-1aa8fac3f03b", "Q3", "AMERICAN SOCIETY FOR CLINICAL PATHOLOGY", 3435, "AMERICAN SOCIETY FOR CLINICAL PATHOLOGY", 2016, "third_quarter", "MED", "Affordable Care Act Implementation; Medicare; Medicare Physician Fee Schedule; H.R.5721 - Local Coverage Determination Clarification Act of 2016 Medicare Clinical Laboratory Fee Schedule; Clinical Laboratory Improvement Amendments of 1988; Protecting Access to Medicare Act (PAMA); Medicare Access and CHIP Reauthorization Act; Electronic Health Records; Health Information Technology Reform Act; Physician Quality Reporting System; Stark Self-Referral Reform; Medicare Sustainable Growth Rate; Laboratory Developed Tests; Physician Shortages and Graduate Medical Education; Health Care Personnel Shortages and Allied Health Education; Appropriations for Federal Agencies; Global Health Initiatives; Non-Communicable Disease", "Agency for Healthcare Research & Quality (AHRQ),Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office", null, 60750, 0, 0, "2016-10-10T13:42:25.013000-04:00"], [1874306, "e01894b3-f42c-4521-8bcd-96c8771c6d2d", "Q3", "GROUP HEALTH COOPERATIVE", 17022, "GROUP HEALTH COOPERATIVE", 2016, "third_quarter", "MED", "Health system and medical research topics", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Personnel Management (OPM),SENATE", null, 98000, 0, 0, "2016-10-10T13:44:28.047000-04:00"], [1874330, "c558c83a-0f8c-4de8-bb23-1f67a3149b8f", "Q3", "CAPITOL CONNECTIONS, LLC", 303597, "KELLEY DRYE & WARREN", 2016, "third_quarter", "MED", "Issues related to NIH research and use of NHPs.", "Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2016-10-10T14:36:50.730000-04:00"], [1874437, "8088d00f-23b8-4219-82b4-f55cdcfc8534", "Q3", "MARSHFIELD CLINIC HEALTH SYSTEM", 57830, "MARSHFIELD CLINIC HEALTH SYSTEM", 2016, "third_quarter", "MED", "Protecting Access to Medicare Act of 2014 (PAMA)\nPAMA includes reforms to the Clinical Lab Fee Schedule (CLFS).  This proposed rule for PAMA.  MCHS requested a delay in this proposed rule, changes to expand the definition of applicable lab to represent the true market of all laboratories; requested greater transparency of calculations; more time to allow for gathering data and implementation.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)", null, 90000, 0, 0, "2016-10-10T16:23:12.330000-04:00"], [1874623, "dd92d12b-7c62-47ba-9fcb-34fd266813e1", "Q3", "MR. BRIAN KELLY", 40024191, "INTELLIA THERAPEUTICS", 2016, "third_quarter", "MED", "Gene Editing", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office", 15000, null, 0, 0, "2016-10-11T10:08:03.150000-04:00"], [1874638, "b3042ccb-6dce-4b3b-85f0-3a9d11648ad6", "Q3", "MR. BRIAN KELLY", 40024191, "LUNDBECK PHARMACEUTICALS", 2016, "third_quarter", "MED", "FDA Reform", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2016-10-11T10:08:06.227000-04:00"], [1875022, "23fd604f-4c02-40b1-a35d-ae24075c75f0", "Q3", "NELSON MULLINS RILEY & SCARBOROUGH", 285871, "NATERA, INC.", 2016, "third_quarter", "MED", "Precision Medicine Initiative, biomedical research, maternal health, TRICARE, Medicaid, and genetic testing", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2016-10-11T15:21:20.397000-04:00"], [1875025, "cc96cfb9-b0e7-42e5-81e3-1d2c584170c5", "Q3", "HOLLAND & KNIGHT LLP", 18466, "THE BIOSIMILARS FORUM", 2016, "third_quarter", "MED", "Medicare reimbursement issues, FDA regulation of biosimilars.", "HOUSE OF REPRESENTATIVES,SENATE", 120000, null, 0, 0, "2016-10-11T15:25:21.837000-04:00"], [1875034, "d92d1493-2d1c-482e-bc47-ad822ec7a536", "Q3", "ALZHEIMER'S FOUNDATION OF AMERICA", 323158, "ALZHEIMER'S FOUNDATION OF AMERICA", 2016, "third_quarter", "MED", "H.R. 6- 21st Century Cures initiative \nS. 2067,the Ensuring Useful Research Expenditures is Key for Alzheimers (EUREKA) Act\nSenate HELP Committee companion to 21st Century Cures\nH.R. 5366 - the Alzheimers Breakthrough Sunshine Act", "Administration on Aging,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office", null, 28000, 0, 0, "2016-10-11T15:35:27.543000-04:00"], [1875093, "63d6f17a-a148-48bf-a2d6-236a1bbcef43", "Q3", "NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE", 48975, "NATIONAL ASSOCIATION FOR THE ADVANCEMENT OF COLORED PEOPLE", 2016, "third_quarter", "MED", "Support HR 3285\nOppose HR 2646", "Agriculture, Dept of (USDA),Bureau of Alcohol Tobacco Firearms & Explosives,Bureau of Prisons (BOP),Bureau of the Census,Centers For Medicare and Medicaid Services (CMS),Consumer Financial Protection Bureau (CFPB),Council of Economic Advisers (CEA),Defense, Dept of (DOD),Education, Dept of,Election Assistance Commission (EAC),Environmental Protection Agency (EPA),Equal Employment Opportunity Commission (EEOC),Federal Communications Commission (FCC),Federal Deposit Insurance Corporation (FDIC),Federal Housing Finance Agency (FHFA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Interior, Dept of (DOI),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Credit Union Administration (NCUA),Natl Institute of Standards & Technology (NIST),Natl Telecommunications & Information Administration (NTIA),Office of Faith-Based & Community Initiatives,Office of Management & Budget (OMB),Office of the Comptroller of the Currency (OCC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office", null, 68750, 0, 0, "2016-10-11T16:45:29.953000-04:00"], [1875133, "15642798-2bdd-47a5-a7c3-e608244bcd59", "Q3", "AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS", 1672, "AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS", 2016, "third_quarter", "MED", "Lobbing to House and Senate Appropriations committee chairs and ranking members about NIDCR funding", "HOUSE OF REPRESENTATIVES,SENATE", null, 19929, 0, 0, "2016-10-11T16:49:31.737000-04:00"], [1875197, "054e7b32-5fbc-4ca1-a488-df6f42250254", "Q3", "CONNECT 4 STRATEGIES, LLC", 401103720, "THERABRON THERAPEUTICS, INC", 2016, "third_quarter", "MED", "HR1573 & S1878 Pediatric Pediatric Priority Review Voucher", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2016-10-11T20:41:26.763000-04:00"], [1875550, "cbc0dff1-e931-4125-a78f-e2f7cc7ed9f2", "Q3", "ARNALL GOLDEN GREGORY, LLP", 400713137, "PHARMA AND BIOPHARMA OUTSOURCING ASSOCIATION", 2016, "third_quarter", "MED", "FDA oversight issues of generic drugs; issues regarding generic drug user fees; 21st Century CURES Act; Innovation for Healthier Americans Act", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2016-10-12T14:00:01.390000-04:00"], [1876129, "c5b44359-53ae-4263-8f95-e3c5c8e896fd", "Q3", "PARALYZED VETERANS OF AMERICA", 30724, "PARALYZED VETERANS OF AMERICA", 2016, "third_quarter", "MED", "S. 800, the Enhancing the Stature and Visibility of Medical Rehabilitation Research at the National Institutes of Health\nDepartment of Veterans Affairs, Medical Research Issues\nNational Institutes of Health, Medical Research Issues", "HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE", null, 69613, 0, 0, "2016-10-13T08:56:40.207000-04:00"], [1876134, "29cc556f-98a2-457e-b398-00f3ff4c319c", "3A", "AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES", 1524, "AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO", 2016, "third_quarter", "MED", "Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325\n\nCost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, \"Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components\"", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2016-10-13T09:04:44.030000-04:00"], [1876398, "8cc4ccf7-ac28-43a6-b7b1-8670e311512c", "Q3", "ACT FOR NIH", 401103441, "ACT FOR NIH", 2016, "third_quarter", "MED", "Advancing biomedical research; immediate restoration of funding for NIH", "HOUSE OF REPRESENTATIVES,SENATE", null, 140000, 0, 0, "2016-10-13T11:02:01.040000-04:00"], [1876511, "e60274a1-8421-49d3-a0e7-c8d6f8d7c9e4", "Q3", "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 1466, "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 2016, "third_quarter", "MED", "AACC contacted Senate HELP leaders to urge that the CLIA amendments be modernized to address concerns regarding oversight of laboratory developed tests rather than expanding Food and Drug Administration oversight of the tests.", "HOUSE OF REPRESENTATIVES,SENATE", null, 40000, 0, 0, "2016-10-13T11:46:26.660000-04:00"], [1876513, "a5d9829f-a6cc-4484-9531-e4a38a73b3e1", "Q3", "TCH GROUP, LLC", 51478, "INTERNATIONAL AIDS VACCINE INITIATIVE", 2016, "third_quarter", "MED", "The House (HR 5912) and Senate (S 3117) FY 17 State Foreign Operations Appropriations bill, and the Continuing Resolution (HR 5325).  Specifically, Federal funding for AIDS vaccine research and development.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2016-10-13T11:47:29.053000-04:00"], [1876577, "81996310-4130-415e-89ae-2c158b46b426", "Q3", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA", 2016, "third_quarter", "MED", "Issues related to priority review voucher for tropical diseases.", "HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB)", 10000, null, 0, 0, "2016-10-13T12:45:22.377000-04:00"], [1876587, "8e25f4bf-d2b2-4014-b725-eeccc71deefb", "Q3", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "NANOMEDICINES ALLIANCE", 2016, "third_quarter", "MED", "Research and development related to nanomedicine", null, null, null, 0, 0, "2016-10-13T12:54:30.170000-04:00"], [1876588, "b9970046-fe24-4190-831b-ff50368c815d", "Q3", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE", 2016, "third_quarter", "MED", "Public Health Programs for Infectious and Tropical Disease; NIH Research; Issues related to government agency conference travel.", "Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,U.S. Agency for International Development (USAID)", 30000, null, 0, 0, "2016-10-13T12:58:31.393000-04:00"], [1876610, "e582a0fe-cb05-441b-bc92-bce8e8ce48fc", "Q3", "MARIJUANA POLICY PROJECT", 74330, "MARIJUANA POLICY PROJECT", 2016, "third_quarter", "MED", "Lobbied House and Senate lawmakers for the removal of onerous, duplicative, and unnecessary barriers to research into potential medical applications of marijuana.", "HOUSE OF REPRESENTATIVES,SENATE", null, 20000, 0, 0, "2016-10-13T13:13:43.867000-04:00"], [1876721, "b9bd679a-5149-4ac9-8be4-b1d191dfa3d6", "Q3", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "ALLIANCE FOR BIOSECURITY", 2016, "third_quarter", "MED", "BioShield Project; Biomedical Countermeasures; Biodefense Research and Development Authority; Pandemic and All-Hazards Preparedness Reauthorization (H.R. 2405 and the Public Law); H.R. 1300, the First Responder Anthrax Preparedness Act; S.2055, Medical Countermeasure Innovations Act of 2015 provision regarding priority review vouchers contracting; Companion bill to H.R. 6, 21st Century Cures Act; extended immunity from tort liability for claims of loss caused by countermeasures against diseases or other threats of public health emergencies under the Public Readiness and Emergency Preparedness Act of 2005 Pub.L.No. 109-417 (120STAT.2831); H.R. 3299, Strengthening Public Health Emergency Response Act of 2015, provisions regarding priority review vouchers contracting; S.1915 First Responder Anthrax Preparedness Act; H.R. 2577, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act of 2017, provisions relating to the Zika supplemental bill.", "Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 40000, null, 0, 0, "2016-10-13T14:00:59.910000-04:00"], [1876876, "bdca270d-4e04-464f-81f1-6866af232406", "Q3", "HACKENSACK MERIDIAN HEALTH", 401104109, "HACKENSACK MERIDIAN HEALTH", 2016, "third_quarter", "MED", "National Institutes of Health appropriations\n340B designation and funding\nBehavioral health funding\n21st Century Cures\nSubstance abuse, opioids, and patient data", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 25000, 0, 0, "2016-10-13T15:39:56.777000-04:00"], [1877617, "c465a15c-09bf-46a3-99b9-9512304e8090", "Q3", "GRIZZLE COMPANY", 16987, "UNIVERSITY OF LOUISVILLE", 2016, "third_quarter", "MED", "HR 5549 The Medical Marijuana Research Act.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2016-10-14T13:01:20.140000-04:00"], [1877625, "6e410325-6675-41bd-bcd3-74afabc721c2", "Q3", "RAY C CULVER III", 11468, "ARKANSAS CHILDREN'S HOSPITAL", 2016, "third_quarter", "MED", "Funding for USDA Agricultural Research Service human nutrition research centers in the FY2017 Agricultural Appropriations/Continuing Resolution/Omnibus bills.", "Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2016-10-14T13:04:23.833000-04:00"], [1877724, "a363ba9b-d5e4-4095-97c4-bdea951394de", "Q3", "FAEGRE BAKER DANIELS CONSULTING", 34158, "MYRIAD GENETIC LABORATORIES, INC.", 2016, "third_quarter", "MED", "FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and FDA.", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2016-10-14T14:27:49.813000-04:00"], [1877734, "b6bee92f-22cd-4369-a580-bd32980c6624", "Q3", "VAN FLEET ASSOCIATES", 39781, "BELLUS MEDICAL", 2016, "third_quarter", "MED", "Gain approval of specific medical technologies (microneedling) regulated by the Federal Food and Drug Administration.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2016-10-14T14:36:58.953000-04:00"], [1877805, "c95428fa-419e-44b7-8a54-0c5351d0caff", "Q3", "THE PETRIZZO GROUP, INC.", 305932, "FRED HUTCHINSON CANCER RESEARCH CENTER", 2016, "third_quarter", "MED", "Advocated for funding of NIH and NCI.  Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms and in favor of legislation to promote medical innovation. Advocated in favor of National Cancer Moonshot Initiative.  Advocated for improvements to FDA approval process.  Advocated in favor of standardized electronic medical records.", "HOUSE OF REPRESENTATIVES,SENATE,White House Office", 50000, null, 0, 0, "2016-10-14T15:04:38.207000-04:00"], [1877809, "f24572ab-6c64-4db9-adc3-5d8f41fe912e", "Q3", "THE PETRIZZO GROUP, INC.", 305932, "ALLEN INSTITUTE", 2016, "third_quarter", "MED", "Advocated for funding of the BRAIN Initiative and full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2016-10-14T15:05:42.160000-04:00"], [1877813, "c17a2b0d-5408-49d5-9e0d-1240cf3c9ca7", "Q3", "THE PETRIZZO GROUP, INC.", 305932, "OMEROS CORPORATION", 2016, "third_quarter", "MED", "Advocated for Medicare packaged payment reform.  Advocated for the Ensuring Equal Access to Treatments Act (H.R. 1178 / S. 1466), to protect patient access to lifesaving medical procedures and breakthrough eye surgery.  Advocated for improvements to FDA approval process.", "HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2016-10-14T15:06:46.303000-04:00"], [1877895, "4a6bd879-dcf9-4034-afeb-923389534579", "Q3", "LNE GROUP", 308811, "PARKER HANNIFIN", 2016, "third_quarter", "MED", "Lobbied for Issues Related to Medical/Disease Research/ Clinical Labs", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2016-10-14T15:18:27.990000-04:00"], [1878044, "48fc002b-e11a-4892-bb05-5c660062154a", "Q3", "PERSONALIZED MEDICINE COALITION", 40046362, "PERSONALIZED MEDICINE COALITION", 2016, "third_quarter", "MED", "Personalized medicine regulation, CMS coverage of personalized medicines and diagnostics & PAMA implementation, CER and Genomics, FDA regulation of personalized medicine, regulation of laboratory developed tests, 21st Century Cures Initiative, Healthier Americans Initiative, Precision Medicine Initiative and Cancer Moonshot task-force, medical device and prescription drug user-fees", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 10000, 0, 0, "2016-10-14T16:28:01.517000-04:00"], [1878270, "8ee5b21d-f13e-4fb4-b25a-281bfd6e5f0d", "Q3", "THE CJR GROUP, INC.", 288293, "UNIVERSITY HOSPITALS HEALTH SYSTEM", 2016, "third_quarter", "MED", "Medical issues relating to hospitals", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2016-10-15T11:13:11.117000-04:00"], [1878384, "fac643c7-e329-401b-8035-6d332e6700bd", "Q3", "FRANCIS EDWARD & CRONIN, INC.", 311314, "CURE ALZHEIMER'S FUND", 2016, "third_quarter", "MED", "issues and legislation related to Alzheimer's disease research.", "Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office", 10000, null, 0, 0, "2016-10-16T17:12:21.363000-04:00"], [1878476, "6231e146-bc9d-440f-858b-d03f66101654", "Q3", "SRI INTERNATIONAL", 90990, "SRI INTERNATIONAL", 2016, "third_quarter", "MED", "FY17 Labor/HHS/Education Appropriations (House and Senate)\n21st Century Cures Act", "HOUSE OF REPRESENTATIVES,SENATE", null, 8000, 0, 0, "2016-10-17T08:51:12.230000-04:00"], [1878482, "f7d70230-2f3a-45ff-aa59-5c8722ce64c9", "Q3", "WILLIAMS AND JENSEN, PLLC", 41454, "BIOGEN IDEC", 2016, "third_quarter", "MED", "21st Century Cures Initiative, H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee); medical research at NIH.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2016-10-17T08:51:13.653000-04:00"], [1878486, "3b94d7cb-d8a3-4720-be03-a04063cc0749", "Q3", "WILLIAMS AND JENSEN, PLLC", 41454, "VERTEX PHARMACEUTICALS INCORPORATED", 2016, "third_quarter", "MED", "21st Century Cures Initiative H.R. 6 (House Energy and Commerce Committee) and Innovation for Healthier Americans (Senate HELP Committee), including efforts to advance precision medicine.  S. 2030 Advancing Targeted Therapies for Rare Diseases Act of 2015.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2016-10-17T08:52:14.793000-04:00"], [1878622, "0a7354b2-573c-479c-8b73-03a673cbabfd", "Q3", "AMERICAN ASSOCIATION FOR DENTAL, ORAL, AND CRANIOFACIAL RESEARCH", 40049382, "AMERICAN ASSOCIATION FOR DENTAL, ORAL, AND CRANIOFACIAL RESEARCH", 2016, "third_quarter", "MED", "Accelerating Biomedical Research Act (S. 318/H.R. 531), 21st Century Cures Act (H.R. 6), Senate HELP Committee Innovation for Healthier Americans initiative and other legislative proposals pertinent to NIH policy.", "HOUSE OF REPRESENTATIVES,SENATE", null, 20000, 0, 0, "2016-10-17T09:58:34.137000-04:00"], [1879228, "5c5f209e-5c3c-48af-b65a-9951aaae65cb", "Q3", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "PREECLAMPSIA FOUNDATION", 2016, "third_quarter", "MED", "Preeclampsia Research Issues; maternal mortality.", "Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH)", 10000, null, 0, 0, "2016-10-17T13:13:38.437000-04:00"], [1879394, "d3f494c1-cd1d-4397-8d91-9920df2ef519", "Q3", "AMERICAN ASSOCIATION FOR CANCER RESEARCH", 400601833, "AMERICAN ASSOCIATION FOR CANCER RESEARCH", 2016, "third_quarter", "MED", "H.R. 6, 21st Century Cures Act\nSenate Innovation Initiative\nLaboratory-developed tests", "HOUSE OF REPRESENTATIVES,SENATE", null, 30000, 0, 0, "2016-10-17T13:46:04.713000-04:00"], [1879672, "52c11390-1aee-4898-85c8-34ad27f6a9c5", "Q3", "AMERICAN CLINICAL LABORATORY ASSN", 1923, "AMERICAN CLINICAL LABORATORY ASSN", 2016, "third_quarter", "MED", "Reimbursement and coverage issues related to the Medicare Clinical Laboratory Fee Schedule and the Physician Fee Schedule, including implementation of the Protecting Access to Medicare Act (P.L. 113-93) and cost-sharing for clinical laboratory services under Part B;  H.R. 6, 21st Century Cures Act; the regulation and oversight of clinical laboratories, including laboratory-developed tests; narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; H.R. 2, the Medicare Access and CHIP Reauthorization of 2015; and H.R 4909, the National Defense Authorization Act for Fiscal Year 2017.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 199612, 0, 0, "2016-10-17T14:37:32.477000-04:00"], [1880003, "882c94d5-5fb0-4d5c-9cb8-9e38c9b189bf", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "AMERICAN BRAIN TUMOR ASSOCIATION", 2016, "third_quarter", "MED", "FY 17 Defense Appropriations Act, cancer research, HR 5293/S.3000\nFY 17 Labor-HHS-Education Appropriations Act, S. 3040/ H.R. 5926, NIH, Cancer Research\nS. 2943, National Defense Authorization Act, funding for Department of Defense Medical research.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 20000, null, 0, 0, "2016-10-17T15:39:58.033000-04:00"], [1880079, "dd10007c-b2dd-4770-81da-1b8e8144e379", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "TUBEROUS SCLEROSIS ALLIANCE", 2016, "third_quarter", "MED", "S.3040; H.R. 5926, FY 2017, Labor-HHS-Education Appropriations bill, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention.\nHR 5293/ S. 3000, FY 2017, Defense Appropriations, FY 2017 defense health programs, Tuberous Sclerosis Complex Research Program.\nS. 2943, National Defense Authorization Act, Funding for Department of Defense Medical Research.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2016-10-17T15:53:52.670000-04:00"], [1880089, "bf22fccc-0f3a-4530-9ba4-555064a2e89e", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION", 2016, "third_quarter", "MED", "Research opportunities at the Department of Defense and the Centers for Disease Control.\nS. 3040/ H.R. 5926, FY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders\nH.R. 5293/ S.3000, FY 2017 Defense Appropriations Act, defense health programs\nH.R. 1849, HHT Diagnosis and Treatment Act\nS. 2943, National Defense Authorization Act, Funding for Department of Defense Medical research.", "Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 10000, null, 0, 0, "2016-10-17T15:56:00.220000-04:00"], [1880359, "a1c662cf-e2a8-4ab8-80e9-17718dfbdc0b", "Q3", "MCDERMOTT+ LLC", 401103287, "COALITION FOR 21ST CENTURY MEDICINE", 2016, "third_quarter", "MED", "Issues concerning regulation of laboratory-developed tests.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 80000, null, 0, 0, "2016-10-17T16:40:32.150000-04:00"], [1880601, "013a7fe5-4099-4249-adcf-4b50282d2e1d", "Q3", "CARDINAL HEALTH, INC.", 58055, "CARDINAL HEALTH INC", 2016, "third_quarter", "MED", "H.R. 6: 21st Century Cures Act (entire bill)\nMedical Device Tax", "HOUSE OF REPRESENTATIVES,SENATE", null, 340000, 0, 0, "2016-10-17T17:52:29.260000-04:00"], [1880878, "2ed59c81-f722-43ec-9471-9ce976ba5550", "Q3", "THORN RUN PARTNERS", 400534596, "CONTINUING MEDICAL EDUCATION COALITION", 2016, "third_quarter", "MED", "H.R.293/S.2978, Protect Continuing Physician Education and Patient Care Act.  \nH.R.6, 21st Century Cures Act.\nS.2153, Provider Payment Sunshine Act.\nIssues related to the promotion of continuing medical education and the implementation of the Physician Payment Sunshine Act.\nImplementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2016-10-18T09:34:19.963000-04:00"], [1880894, "019f3d44-5e52-4071-9e73-d1c6a8b1df03", "Q3", "THORN RUN PARTNERS", 400534596, "NOVARTIS CORPORATION", 2016, "third_quarter", "MED", "Issues related to biologics.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2016-10-18T09:40:31.733000-04:00"], [1880943, "a2b06e5c-6057-4ea4-b42f-cdd07728c3e5", "Q3", "THORN RUN PARTNERS", 400534596, "CHILDRENS HOSPITAL COLORADO", 2016, "third_quarter", "MED", "Issues related to pediatric research and childrens hospital graduate medical education.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2016-10-18T09:53:57.760000-04:00"], [1880945, "c711567c-8ef3-49d3-bbc8-61ca26c59c0d", "Q3", "THORN RUN PARTNERS", 400534596, "ABBVIE INC.", 2016, "third_quarter", "MED", "Issues related to National Institutes of Health (NIH), Centers for Disease Control (CDC), and other funding.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2016-10-18T09:56:00.107000-04:00"], [1880974, "61ea358d-9cba-44e8-aa1b-d33a59a1bffe", "Q3", "THORN RUN PARTNERS", 400534596, "ABBOTT LABORATORIES", 2016, "third_quarter", "MED", "Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2016-10-18T09:58:07.030000-04:00"], [1881163, "4371ab87-4586-4ab9-83ab-5b9d9a423265", "Q3", "NORTHWESTERN UNIV", 299992, "NORTHWESTERN UNIV", 2016, "third_quarter", "MED", "S. 289/H.R. 2104 American Cures Act, entire bill.\n\nS. 318/H.R. 531 Accelerating Biomedical Research Act, entire bill.\n\nH.R. 6, 21st Century Cures Act, Title I and II.\n\nH.R. 2124/S. 1148, Resident Physician Shortage Reduction Act, entire bill.\n\nS. 2713, Advancing Precision Medicine Act of 2016, entire bill.", "HOUSE OF REPRESENTATIVES,SENATE", null, 176233, 0, 0, "2016-10-18T10:33:16.607000-04:00"], [1881194, "772c5758-6868-46ef-9c1b-4b40a411f43c", "Q3", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "CITY OF HOPE MEDICAL CENTER", 2016, "third_quarter", "MED", "Medicare/Medicaid reimbursement, clinical research", "HOUSE OF REPRESENTATIVES", 30000, null, 0, 0, "2016-10-18T10:36:35.970000-04:00"], [1881247, "7aab7c8c-9d0c-4604-8bc2-6104af9086f4", "Q3", "NESTLE USA", 29037, "NESTLE USA", 2016, "third_quarter", "MED", "Medical Foods Equity Act. S. 2736/H.R. 5210 Patient Access to Durable Medical Equipment Act.", "Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Pension Benefit Guaranty Corporation (PBGC),SENATE,Treasury, Dept of", null, 440000, 0, 0, "2016-10-18T10:45:05.103000-04:00"], [1881421, "ff2d70ff-9d4c-4d75-9d0e-27edaf2f8909", "3A", "NORTHWESTERN UNIV", 299992, "NORTHWESTERN UNIV", 2016, "third_quarter", "MED", "S. 289/H.R. 2104 American Cures Act, entire bill.\n\nS. 318/H.R. 531 Accelerating Biomedical Research Act, entire bill.\n\nH.R. 6, 21st Century Cures Act, Title I and II.\n\nH.R. 2124/S. 1148, Resident Physician Shortage Reduction Act, entire bill.\n\nS. 2713, Advancing Precision Medicine Act of 2016, entire bill.", "HOUSE OF REPRESENTATIVES,SENATE", null, 177513, 0, 0, "2016-10-18T11:10:32.017000-04:00"], [1881583, "60d4dab7-92f7-45d0-b85f-a7ba0504cb50", "Q3", "TODD STRATEGY GROUP", 401103321, "BIODESIX, INC.", 2016, "third_quarter", "MED", "FDA regulation of laboratory developed tests.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2016-10-18T11:33:05.723000-04:00"], [1881601, "ec438e5b-6806-47a1-9668-6e5a1546d482", "Q3", "THORN RUN PARTNERS", 400534596, "HACKENSACK MERIDIAN HEALTH", 2016, "third_quarter", "MED", "Issues relating to research funding, NIH and other matters.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2016-10-18T11:34:15.413000-04:00"], [1881615, "c5be9cd1-4745-4b41-9a14-6a215bcd6178", "Q3", "TODD STRATEGY GROUP", 401103321, "MYRIAD GENETIC LABORATORIES INC", 2016, "third_quarter", "MED", "FDA draft guidance to regulate laboratory developed tests and companion diagnostics.\nLegislation to further regulate clinical labs under CLIA and/or FDA (legislation not yet introduced).", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2016-10-18T11:36:22.650000-04:00"], [1881640, "5d27655b-4674-445b-b36b-77a2328ee879", "Q3", "TODD STRATEGY GROUP", 401103321, "VERACYTE, INC.", 2016, "third_quarter", "MED", "FDA regulation of laboratory developed tests.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2016-10-18T11:38:34.277000-04:00"], [1881779, "696053bc-7a1e-4f21-a1e0-3ba223e3d2e4", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "ENDOCRINE SOCIETY", 2016, "third_quarter", "MED", "Research in Endocrinology; HR 6 House 21st Century Cures bill; Senate Innovations for Healthier Americans bill, S. 2745; HR 2101 Research for All act of 2015; inclusion in research; S. 1101 MEDTECH Act", "Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 30000, null, 0, 0, "2016-10-18T12:00:50.233000-04:00"], [1881785, "154908f0-94cb-44a4-bd02-fd0ded9da77b", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "NATIONAL ASSOCIATION OF EPILEPSY CENTERS", 2016, "third_quarter", "MED", "Research and public health programs in epilepsy.", "Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 10000, null, 0, 0, "2016-10-18T12:01:55.530000-04:00"], [1881805, "9c27e79a-87d3-4515-979a-70a1cadee1a7", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "AMERICAN SOCIETY OF HEMATOLOGY", 2016, "third_quarter", "MED", "Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease.\n\nHR 1807, Sickle Cell Disease Research Surveillance Prevention and Treatment Act of 2015; Resolution on Sickle Cell Disease Trait", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 30000, null, 0, 0, "2016-10-18T12:05:03.580000-04:00"], [1881827, "702e2f60-a412-4860-958c-6ad7f97e03c3", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "NATIONAL HEMOPHILIA FOUNDATION", 2016, "third_quarter", "MED", "Hemophilia research, prevention, surveillance and service programs and issues.", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE", 50000, null, 0, 0, "2016-10-18T12:06:14.973000-04:00"], [1881921, "06e798e2-fdbb-432b-a727-db865163d80d", "Q3", "LOCKRIDGE, GRINDAL, NAUEN, PLLP", 23053, "HENNEPIN COUNTY MEDICAL CENTER", 2016, "third_quarter", "MED", "FY2017 Authorizations, Appropriations, and Budget Policy", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2016-10-18T12:22:13.097000-04:00"], [1882078, "c8ad2c35-72ae-49ba-bfe8-30c8efcd4d54", "Q3", "STANFORD UNIVERSITY", 36492, "STANFORD UNIVERSITY", 2016, "third_quarter", "MED", "Health Professions Programs\n\nGraduate Medical Education Funding\n\nS1148; HR2124\nResident Physician Shortage Reduction Act of 2015\n\nPrecision Medicine", "Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE", null, 60000, 0, 0, "2016-10-18T12:52:49.283000-04:00"], [1882571, "cc520144-690f-49b1-a02c-c45354b23047", "Q3", "INTUITIVE SURGICAL, INC.", 400670004, "INTUITIVE SURGICAL, INC.", 2016, "third_quarter", "MED", "comparative effectiveness research in healthcare;  medical research issues", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, 30000, 0, 0, "2016-10-18T14:03:29.447000-04:00"], [1882794, "8c314fee-446e-4478-a231-c97bcabbdd81", "Q3", "SQUIRE PATTON BOGGS", 30906, "UNIVERSITY OF GEORGIA", 2016, "third_quarter", "MED", "Traumatic brain injury research, funding, and outreach opportunities. Zika research funding.", "Commerce, Dept of (DOC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID)", 40000, null, 0, 0, "2016-10-18T14:34:02.100000-04:00"], [1883599, "01cb01c1-3cb9-40a8-8126-67c0c6e7b8e7", "Q3", "ISEMAN & ASSOCIATES LLC", 401103582, "TICHENOR VENTURES, LLC", 2016, "third_quarter", "MED", "Monitoring biotech legislation", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2016-10-18T16:17:17.613000-04:00"], [1883775, "001f49b8-6b41-4749-8121-45939c1f5467", "Q3", "WEBMD HEALTH CORP.", 55473, "WEBMD HEALTH CORP", 2016, "third_quarter", "MED", "Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers.  Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records. S.2978 (Barrasso R-WY) --- A Bill to amend title XI of the Social Security Act to exempt certain transfers for educational purposes from manufacturer transparency reporting requirements).", "SENATE", null, 10000, 0, 0, "2016-10-18T16:54:04.333000-04:00"], [1884726, "e13a43de-aa82-45ae-892a-164ea4acfe77", "Q3", "VAN SCOYOC ASSOCIATES", 39837, "AMERICAN CLINICAL LABORATORY ASSOCIATION", 2016, "third_quarter", "MED", "No lobbying activity.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2016-10-19T07:44:47.813000-04:00"], [1884824, "f94a2f30-034b-442a-b17d-c8ba94dce0e1", "Q3", "RAMPY NORTHRUP LLC", 401103289, "AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)", 2016, "third_quarter", "MED", "Implementation of P.L.113-93, Protecting Access to Medicare Act of 2014 (changes to reimbursement for clinical laboratory services). \nProposals concerning the Stark Law's in-office ancillary services exception. \nPolicies impacting Medicare reimbursement for clinical laboratory services. \nFDA regulation of clinical laboratory services. \nH.R.6, 21st Century Cures Act.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2016-10-19T08:57:37.317000-04:00"], [1884962, "db4b4e3d-c0f4-4f7b-9806-25f8bfeb868c", "Q3", "CAPITOL HILL STRATEGIES,  LLC", 91774, "PHRMA", 2016, "third_quarter", "MED", "S. 320, The Medical Innovation Act.  Legislation to authorize the collection of supplemental payments to increase congressional investments in medical research.\nH.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets)\nSenate Innovations for Healthy Americans Act (text not yet available but likely multiple provisions similar to H.R. 6 including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets)\nS. 1878, Advancing Hope Act of 2015 legislation that amends the Federal Food, Drug, and Cosmetic Act to expand the priority review voucher program for rare pediatric diseases to include treatments for sickle cell disease and pediatric cancers.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2016-10-19T09:38:03.147000-04:00"], [1885006, "6b59ee56-53d2-4601-9d15-2c144303e3fb", "Q3", "CAPITOL HILL STRATEGIES,  LLC", 91774, "BIOTECHNOLOGY INDUSTRY ORGANIZATION", 2016, "third_quarter", "MED", "H.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets)\nS. 320, The Medical Innovation Act.  Legislation to authorize the collection of supplemental payments to increase congressional investments in medical research.\nSenate Innovations for Healthy Americans Act (text not yet available but likely multiple provisions similar to H.R. 6 including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets)\nS. 1878, Advancing Hope Act of 2015 legislation that amends the Federal Food, Drug, and Cosmetic Act to expand the priority review voucher program for rare pediatric diseases to include treatments for sickle cell disease and pediatric cancers.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2016-10-19T09:57:31.963000-04:00"], [1885102, "f120538d-76c8-4546-ba79-e4bc164e89ce", "Q3", "VAN SCOYOC ASSOCIATES", 39837, "UNIVERSITY OF NOTRE DAME", 2016, "third_quarter", "MED", "Zika virus research and development related issues", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2016-10-19T10:07:22.127000-04:00"], [1885122, "47f335c5-ea63-480c-814a-f94ade459458", "Q3", "CAPITOL HILL STRATEGIES,  LLC", 91774, "BIOGEN INC", 2016, "third_quarter", "MED", "H.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets)\nIssues dealing with newborn screening.\nS. 1878, Advancing Hope Act of 2015 legislation that amends the Federal Food, Drug, and Cosmetic Act to expand the priority review voucher program for rare pediatric diseases to include treatments for sickle cell disease and pediatric cancers.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2016-10-19T10:09:36.503000-04:00"], [1885444, "8e857456-c107-4ecb-936e-74667a040eaa", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "ASSOCIATION FOR MOLECULAR PATHOLOGY", 2016, "third_quarter", "MED", "Precision Medicine Initiative\nRegulation of laboratory diagnostics", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,White House Office", 60000, null, 0, 0, "2016-10-19T10:45:00.457000-04:00"], [1885452, "560b662e-2d5f-4005-a6d8-d5cd8b8d6e6f", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "COUNSYL", 2016, "third_quarter", "MED", "Regulation and oversight of diagnostics\nCancer Moonshot\nReimbursement of diagnostics", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE", 30000, null, 0, 0, "2016-10-19T10:46:08.817000-04:00"], [1885471, "c35028f8-202a-43dd-aca6-a262b3784326", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "ICAHN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY", 2016, "third_quarter", "MED", "Next generation sequencing based diagnostics", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2016-10-19T10:48:19.287000-04:00"], [1885557, "d6b00a05-ecab-45ac-b4f5-937f07cf137d", "Q3", "HOLLAND & KNIGHT LLP", 18466, "PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION", 2016, "third_quarter", "MED", "Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; the FY 2017 Ag-FDA Appropriations bill (S.1800 & H.R. 5054); Implementation of the White House Cancer Moonshot Task Force.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE,White House Office", 90000, null, 0, 0, "2016-10-19T10:55:16.733000-04:00"], [1885607, "946e88bf-3b49-4a23-8c56-057c61a704d2", "Q3", "UNIVERSITY OF ROCHESTER", 301937, "UNIVERSITY OF ROCHESTER", 2016, "third_quarter", "MED", "S. 289, America Cures Act\nH.R. 6, 21st Century Cures Act\nS. 2742, Promoting Biomedical Research and Public Health for Patients Act", "HOUSE OF REPRESENTATIVES,SENATE", null, 90000, 0, 0, "2016-10-19T10:58:45.237000-04:00"], [1885713, "5c496afc-5254-453b-a074-e4ba3ea9e82d", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "CURE FORWARD", 2016, "third_quarter", "MED", "Precision Medicine Initiative \nCancer Moonshot\nPatient Access to lab Results\nRegulation of Health Software\nHR 6 21st Century Cures\nS. 1101 MEDTECH Act", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2016-10-19T11:07:34.023000-04:00"], [1885728, "1bbf3d81-1ec4-4d84-89cf-41009f0d0bac", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "23ANDME, INC.", 2016, "third_quarter", "MED", "Direct to consumer genetic testing\nRegulation and oversight of diagnostics\nPrecision Medicine Initiative\nS.2744, Genetic Research Privacy Protection Act", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE", 20000, null, 0, 0, "2016-10-19T11:08:44.963000-04:00"], [1885758, "eec4ea21-cebe-40dc-946a-d0dbe9c2d0d7", "Q3", "CURATORS OF THE UNIVERSITY OF MISSOURI", 43616, "CURATORS OF THE UNIVERSITY OF MISSOURI", 2016, "third_quarter", "MED", "21st Century Cures Act, all issues relating to the National Institutes of Health (NIH) and the NIH Innovation Fund. \nS. 2742 Promoting Biomedical Research and Public Health for Patients Act, all issues\nS. 2700 National Institutes of Health (NIH) Workforce Authorities Modernization Act, all issues\nS. 2713 Advancing Precision Medicine Act of 2016, all issues\nS. 2745 Advancing NIH Strategic Planning and Representation in Medical Research Act, all issues\nS. 2742 Promoting Biomedical Research and Public Health for Patients Act, all issues\nHR5395, S.2873 ECHO Act, all issues.  \nH.R. 2713/S. 3245 Title VIII Nursing Workforce Reauthorization Act of 2015, all issues", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", null, 80000, 0, 0, "2016-10-19T11:13:05.827000-04:00"], [1886015, "ba61897c-d751-4914-a5a5-2a9ebff6904e", "Q3", "FORBES-TATE", 400976792, "AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION", 2016, "third_quarter", "MED", "Issues related to Medicare and Medicaid payments to physicians; issues related to medical imaging; issues related to Sustained Growth Rate (SGR); issues related to medical imaging within the VA system.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2016-10-19T11:37:26.177000-04:00"], [1886087, "81b2f2a6-4529-46b9-b907-5f216f6d8bfb", "Q3", "UNIVERSITY OF IOWA", 49191, "UNIVERSITY OF IOWA", 2016, "third_quarter", "MED", "Residency Caps\nMinority Improvement\nNIOSH Education and Research Centers for Occupational Health and Safety\nFY 16 Appropriations\nFY 17 Appropriations\nPrevention Research Centers\nResident Physician Shortage\nHealth Care Reform\n21st Century Cures Act\nNIH chimera research guidelines", "Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)", null, 86662, 0, 0, "2016-10-19T11:40:55.943000-04:00"], [1886186, "0975ee42-2378-4007-8ed0-2a8c04bfb791", "Q3", "THE PAUL LAXALT GROUP", 22325, "THE ROGOSIN INSTITUTE", 2016, "third_quarter", "MED", "The Chronic Kidney Disease Improvement in Research and Treatment Act S.598 H.R.1130.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2016-10-19T11:51:37.017000-04:00"]], "truncated": false, "filtered_table_rows_count": 268, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_period\" = :p0 and \"filing_year\" = :p1 and \"issue_code\" = :p2 order by filing_year desc limit 101", "params": {"p0": "third_quarter", "p1": "2016", "p2": "MED"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2016&issue_code=MED", "results": [{"value": "MED", "label": "MED", "count": 268, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2016", "selected": true}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2016&issue_code=MED", "results": [{"value": 2016, "label": 2016, "count": 268, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&issue_code=MED", "selected": true}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2016&issue_code=MED", "results": [{"value": "third_quarter", "label": "third_quarter", "count": 268, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_year=2016&issue_code=MED", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "filing_type", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2016&issue_code=MED&_facet=filing_type"}, {"name": "income_amount", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2016&issue_code=MED&_facet=income_amount"}, {"name": "is_termination", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2016&issue_code=MED&_facet=is_termination"}, {"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2016&issue_code=MED&_facet_date=received_date"}], "next": "2016,1886186", "next_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2016&issue_code=MED&_next=2016%2C1886186&_sort_desc=filing_year", "private": false, "allow_execute_sql": true, "query_ms": 2196.1118400795385, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}